Navigation Links
FDA Accepts New Drug Application for NEBIDO(R) Submitted by Indevus
Date:11/1/2007

LEXINGTON, Mass., Nov. 1 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company's New Drug Application (NDA) for NEBIDO(R), its long-acting injectable testosterone preparation for the treatment of male hypogonadism. The FDA Prescription Drug User Fee Act (PDUFA) target action date for NEBIDO is June 27, 2008. The NDA was submitted to the FDA by the Company on August 28, 2007.

The NDA contains data from six clinical studies in which over 400 patients received at least one dose of NEBIDO, with over 300 of these patients treated for more than one year. In total, over 3,000 injections of NEBIDO have been given to hypogonadal males during the clinical development program. In addition, the NDA includes post-marketing data from safety reporting through June 2007, reflecting the world-wide experience from over 260,000 injections of NEBIDO.

About NEBIDO

NEBIDO(R) is a long-acting depot preparation of testosterone undecanoate, developed for the treatment of male hypogonadism. NEBIDO is expected to be the first three-month testosterone preparation available in the U.S. in the growing market for testosterone therapies. Indevus acquired U.S. rights to NEBIDO from Bayer Schering Pharma AG, Germany in July 2005.

About Hypogonadism

Male hypogonadism is an increasingly recognized medical condition characterized by a reduced or absent secretion of testosterone from the testes. Reduced testosterone levels can lead to health problems and significantly impair quality of life. Common effects of hypogonadism include decreased sexual desire, muscle loss and weakness, as well as an increased risk o
'/>"/>

SOURCE Indevus Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Mexico Supreme Court Accepts Petition To Review Mexico City Law Legalizing Abortion During First Three Months Gestation
2. Novartis files application with FDA for Zometa
3. Morepan to file new drug applications with the USFDA
4. Mini motor for micromedical applications
5. Perfusion bioreactor could enhance stem cell research and application in the future
6. Prostate Cancer Can Be Treated By Application Of LASER Technology
7. Varied Applications of Adult Stem Cells to Treat Host of Disorders in Human
8. Venus Remedies Files 5th International Patent Application
9. NICE supports application of advanced biological therapies as treatment option for acute psoriasis
10. Roche puts in an Application to Use Herceptin for Treatment in Her-2 positive breast cancer
11. New Drug Application Submitted for Investigational Antibiotic Doripenem
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... July 31, 2015 , ... The Radiology Business Management ... MD, (R-Tex) presenting “What’s Next for Health Care: A View From Capitol Hill” on ... of the Congressional Health Caucus, Rep. Burgess has a special understanding of the real ...
(Date:7/31/2015)... ... July 31, 2015 , ... Super-Sod wants to participate in planning new ... Page as the perfect fit for such a goal. Houzz is a social ... website is a dynamic site that spreads home and home garden design ideas when ...
(Date:7/31/2015)... ... 2015 , ... Easter Seals Southern Georgia’s Heels & Wheels Duathlon & Triathlon will be held ... 7:30 AM. The duathlon is a 2 mile run, 13 mile bike ride, and a ... 13 mile bike, and a 3 mile run. Heels & Wheels is sponsored by ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... The same logic applies when purchasing disability insurance, where price is an important ... Consultants, along with a leading insurance carrier, offers the Preferred Producer Multi-Life Discount ...
(Date:7/30/2015)... ... July 31, 2015 , ... When responsible for the care ... out-of-reach. The questions race through your mind: What happens if mom falls? Who will ... overwhelmed and cancel your plans. , But not taking time away from caregiving responsibilities ...
Breaking Medicine News(10 mins):Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 2Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 3Health News:Super-Sod Created a Landscape Profile on Houzz.com for Home Garden Design 2Health News:Heels & Wheels for Megan's House Set for Saturday August 22, 2015 in Waycross, Georgia 2Health News:Secura Consultants Gives Advisers Competitive New Edge with Multi-Life Discount Program 2Health News:Aging Life Care Association™ Experts Offer Tips for Caregivers in Need of Vacation Time 2Health News:Aging Life Care Association™ Experts Offer Tips for Caregivers in Need of Vacation Time 3
... ... for creation of offshore worker safety task force to promote interest of oil rig crews ... ... in the Gulf of Mexico once again illustrates the hazardous and sometimes deadly work conditions ...
... two-thirds of women of childbearing age fit the bill ... study says federal guidelines on obesity should be revised ... , U.S. guidelines determine who is obese based on ... and weight are proportional. The researchers found that about ...
... past over the issue , WEDNESDAY, April 21 (HealthDay ... Wednesday proposed new guidelines to help give the public ... its all-important advisory committees, which help approve drugs and ... criticized for allowing individuals with conflict of interests to ...
... ... ... wellness programs depends not only on motivating employees, but also on how supportive companies ... Seven Ways to Build a High-Engagement Wellness Program , scheduled for Thursday, April 22 at ...
... cause pneumonia and meningitis, researchers point out , WEDNESDAY, April ... the PCV7 vaccine to battle bacteria that causes pneumonia, ... changes in strains that cause these illnesses, researchers report. , ... by the vaccine, the team aid. , Immunizations with the ...
... at Johns Hopkins say they have discovered the way in ... following a stroke. , Two hours after feeding mice ... the skins and seeds of red grapes, the scientists induced ... the animals, brains. They found that the animals that had ...
Cached Medicine News:Health News:Explosion on Gulf Coast Oil Rig Underscores Daily Dangers for Maritime Workers, Say Houston Maritime Injury Lawyers Arnold & Itkin LLP 2Health News:More U.S. Women May Be Obese Than Thought 2Health News:FDA to Broaden Disclosure on Advisers' Conflicts of Interest 2Health News:FDA to Broaden Disclosure on Advisers' Conflicts of Interest 3Health News:DSM Personalized Nutrition Webinar Examines Ways to Build Engagement in Wellness Programs 2Health News:DSM Personalized Nutrition Webinar Examines Ways to Build Engagement in Wellness Programs 3Health News:Vaccine Now Misses Many Pneumococcal Infections in Kids 2Health News:How red wine may shield brain from stroke damage 2
(Date:7/30/2015)...  Growth of the U.S. nonprescription market is primarily ... users to the OTC market. Due to an increasingly ... switch activity over the next five years with several ... brands entering the market into existing categories. ... (even those with low to moderate likelihood), the market ...
(Date:7/30/2015)... N.J. , July 30, 2015  Medimetriks ... completed the second Phase III clinical study for ... for impetigo.  Medimetriks owns the exclusive U.S. rights ... global trial, conducted at 44 centers with an ... pediatric patients aged 2 months and older with ...
(Date:7/30/2015)... 2015 Vermillion, Inc. (VRML), a ... announced today it will report its second ... close on Thursday, August 13, 2015, followed ... at 4:30pm Eastern.Conference Call and Webcast:  ... Pacific  Domestic: , 888-430-8691International: ...
Breaking Medicine Technology:Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3
... TLC Vision announced today its plans for opening a ... Diego.  Internationally recognized as leaders in field of refractive surgery, ... will lend their surgical skill and expertise to the TLC ... continue to be at the forefront of working with optometry ...
... Kaiser Permanente,s National Pharmacy Programs and Services was recognized at ... Vegas as a J.D. Power 2011 Customer Service Champion ... the distinction this year. To qualify for ... within their own industries, but also must stand out among ...
Cached Medicine Technology:TLC Vision Announces TLC Laser Eye Center San Diego 2Kaiser Permanente Recognized as a J.D. Power 2011 Customer Service Champion 2